Catalyst Watch: Oracle earnings, Arm IPO lockup, and triple-witching day
Written by Emily J. Thompson, Senior Investment Analyst
Source: SeekingAlpha
Monday - March 11:
- Notable companies like Oracle, Casey's General Stores, and Asana are due to report earnings.
- Online sports betting launches in North Carolina with various companies offering betting apps.
- Several companies including AT&T and eBay will present at the Deutsche Bank Media, Internet & Telecom Conference.
- FTC lawsuit status conference on Albertsons/Kroger deal scheduled for 4:30 p.m.
- Nasdaq to release its latest update on short interest positions postmarket.
Tuesday - March 12:
- Earnings reports expected from companies like Archer-Daniels, Kohl's, and International Game Technology.
- Healthcare sector events include Barclays Global Healthcare Conference and Leerink Partners Global BioPharma Conference.
- Consumer price index report for February to be released at 8:30 a.m.
- Share lockup period for Arm Holdings set to expire.
- Votes scheduled for Karuna Therapeutics/Bristol-Myers deal and Six Flags/Cedar Fair deal.
Wednesday - March 13:
- Earnings reports from Dollar Tree, Petco Health & Wellness, Williams-Sonoma, and Lennar.
- Starbucks annual shareholder meeting with a proxy fight for board seats.
- Kraft Heinz showcasing plant-based products at Natural Products Expo West.
- Various events including HSR refiling for Bristol-Myers deal and European Commission review of Cisco's deal for Splunk.
- U.S. House expected to vote on a bill regarding TikTok divestment.
Thursday - March 14:
- Earnings reports from Dick's Sporting Goods, Dollar General, Adobe, Blink Charging, and Ulta Beauty.
- FDA action date for Madrigal Pharmaceuticals' Resmetirom.
- Atmus Filtration begins trading after being spun off from Cummins.
- Investor events for Azenta and 8x8, along with Leonardo DRS investor day.
- Reports on producer price index, retail sales, and speeches by Bristol Myers and Abbvie at Barclays conference.
Friday - March 15:
- Earnings report from Jabil.
- Triple witching day may bring extra volatility to the stock market.
- Last trading day before FDA action date on OptiNose's Xhance treatment.
- University of Michigan's consumer sentiment report to be released at 10:00 a.m.
Analyst Views on LEN
Wall Street analysts forecast LEN stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for LEN is 122.08 USD with a low forecast of 95.00 USD and a high forecast of 161.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
14 Analyst Rating
2 Buy
9 Hold
3 Sell
Hold
Current: 122.250
Low
95.00
Averages
122.08
High
161.00
Current: 122.250
Low
95.00
Averages
122.08
High
161.00
About LEN
Lennar Corporation is a homebuilder and an originator of residential and commercial mortgage loans. The Company is also a provider of title insurance and closing services, and a developer of multifamily rental properties. The Company's segments include Homebuilding East, Homebuilding Central, Homebuilding Texas, Homebuilding West, Financial Services, Multifamily, and Lennar others. Its Homebuilding segments primarily include the construction and sale of single-family attached and detached homes, as well as the purchase, development and sale of residential land directly and through its unconsolidated entities. The Company's Financial Services segment primarily provides mortgage financing, title and closing services primarily for buyers of its homes, as well as property and casualty insurance. The Company’s Multifamily segment is involved in the development, construction and property management of multifamily rental properties. its Lennar Other segment includes fund investments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
